XmAb-2513 Preis auf Anfrage

Artikelnummer: TGM-T9901A-1897
Artikelname: XmAb-2513 Preis auf Anfrage
Artikelnummer: TGM-T9901A-1897
Hersteller Artikelnummer: T9901A-1897
Alternativnummer: TGM-T9901A-1897-1MG,TGM-T9901A-1897-5MG
Hersteller: TargetMol
Kategorie: Biochemikalien
XmAb-2513 is a humanized monoclonal antibody inhibitor targeting CD30. It demonstrates significant anti-proliferative activity along with excellent antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP). XmAb-2513 is applicable in research on hematological malignancies such as Hodgkin lymphoma (HL) and anaplastic large cell lymphoma (ALCL).
Target-Kategorie: TNF